JESSIE LINDSEY: Open Payments
NPI 1265884175 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 20 payments from 8 companies in 2025. Trend: 2023 $202 · 2024 $615 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| ABBVIE INC. | 10 | $148 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $120 |
| Insmed, Inc. | 1 | $84 |
| Edwards Lifesciences Corporation | 1 | $72 |
| Abbott Laboratories | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, Arikayce, SAPIEN 3 Ultra RESILIA, FREESTYLE LIBRE 3, Qelbree, CAMZYOS, BREZTRI.
Industry payments across MS — which companies pay providers there.
